A Phase 4 interventional study of Antibiotic-Cefamezin in Hand Laceration, Tendon Involved and Clean Laceration, sponsored by HaEmek Medical Center, Israel. Completed. Open to participants aged 13 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-02-17.
Sponsored by HaEmek Medical Center, Israel · Phase 4, Interventional, and Treatment
The investigators assume that simple hand lacerations involving flexors or extensors tendons, do not require prophylactic antibiotic treatment to prevent wound infection.
Hand lacerations are divided to "complicated" which involves tendons, nerves, bones, and joints, and "simple" which involves only cutaneous and subcutaneous tissue.
prophylactic antibiotic should not be given in a clean simple lacerations, and should be given when a bone is involve (open fracture). But there is not enough data, weather prophylactic antibiotic treatment should be given when only tendons are involved. The investigators will examine 2 groups of 30 patients each with clean hand lacerations involving tendons. One group will be treated with prophylactic antibiotic and the other wont be treated, randomly. The investigators assume that the rate of wound infection wont be different between the 2 groups.
133 studies on the registry are indexed under Lacerations; 29 are open to participants now.
This study's enrollment of 24 is below the median of 79 across 106 interventional studies indexed under Lacerations.
Browse Lacerations studies →HaEmek Medical Center, Israel is the lead sponsor of 228 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Antibiotic-Cefamezin
Also known as: Ceforal, Keflex
rate of wound infections
signs of wound/tissue infection, levels of WBC, ESR, CRP
Time frame: 2 years
No study locations are listed for this record.
This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
HaEmek Medical Center, Israel